Cargando…

Efficacy of Binary Ethylenimine in the Inactivation of Foot-and-Mouth Disease Virus for Vaccine Production in South Korea

Foot-and-mouth disease (FMD) vaccines must be produced in a biosafety level 3 facility, so the FMD virus (FMDV) must be completely inactivated after amplification. The inactivation kinetics of FMDV during vaccine antigen production were assessed by evaluating whether the viral titer dropped below 10...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jae Young, Park, Sun Young, Jin, Jong Sook, Kim, Dohyun, Park, Jong-Hyeon, Park, Sang Hyun, Ko, Young-Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303202/ https://www.ncbi.nlm.nih.gov/pubmed/37375450 http://dx.doi.org/10.3390/pathogens12060760

Ejemplares similares

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
por: Park, Sun Young, et al.
Publicado: (2022)

Reemergence of Foot-and-Mouth Disease, South Korea, 2000–2011
por: Park, Jong-Hyeon, et al.
Publicado: (2014)

Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2021)

Production of Foot-and-Mouth Disease Type O and A Vaccine Antigens on a Pilot Scale and Determination of Optimal Amount of Antigen for Monovalent Vaccines
por: Kim, Jae Young, et al.
Publicado: (2023)

Comparison of High-Performance Liquid Chromatography with Sucrose Density Gradient Ultracentrifugation for the Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2022)

Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine
por: Bahnemann, Hans G.
Publicado: (1990)

Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2021)

Control of Foot-and-Mouth Disease during 2010–2011 Epidemic, South Korea
por: Park, Jong-Hyeon, et al.
Publicado: (2013)

Application of equine herpesvirus-1 vaccine inactivated by both formaldehyde and binary ethylenimine in equine
por: Warda, Fatma F., et al.
Publicado: (2021)

Efficient Removal of Non-Structural Protein Using Chloroform for Foot-and-Mouth Disease Vaccine Production
por: Park, Sun Young, et al.
Publicado: (2020)

Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5
por: Kim, Hyejin, et al.
Publicado: (2021)

Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens
por: Park, Sun Young, et al.
Publicado: (2022)

Novel foot-and-mouth disease virus in Korea, July-August 2014
por: Park, Jong-Hyeon, et al.
Publicado: (2016)

Determination of optimal age for single vaccination of growing pigs with foot-and-mouth disease bivalent vaccine in South Korea
por: KIM, Ah-Young, et al.
Publicado: (2017)

Application of Heparin Affinity Chromatography to Produce a Differential Vaccine without Eliciting Antibodies against the Nonstructural Proteins of the Serotype O Foot-and-Mouth Disease Viruses
por: Park, Sun Young, et al.
Publicado: (2020)

Sucrose density gradient centrifugation and cross-flow filtration methods for the production of arbovirus antigens inactivated by binary ethylenimine
por: Pyke, Alyssa T, et al.
Publicado: (2004)

Control of type O foot-and-mouth disease by vaccination in Korea, 2014–2015
por: Park, Jong-Hyeon, et al.
Publicado: (2018)

Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs
por: Park, Sang-Hyun, et al.
Publicado: (2021)

Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease
por: Shin, Seokwon, et al.
Publicado: (2023)

Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents
por: Kim, Su-Mi, et al.
Publicado: (2012)

Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses
por: Lee, Seo-Yong, et al.
Publicado: (2017)

Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A
por: Kim, Dong-Wan, et al.
Publicado: (2023)

Complete Genome Sequence of a Foot-and-Mouth Disease Virus of Serotype O, Isolated from Gochang, Republic of Korea, in 2016
por: Kim, Taeseong, et al.
Publicado: (2017)

Complete Genome Sequence of a Foot-and-Mouth Disease Virus of Serotype O Isolated from Gimje, Republic of Korea, in 2016
por: Ryoo, Soyoon, et al.
Publicado: (2017)

Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface
por: Hwang, Seong Yun, et al.
Publicado: (2023)

Requirements for improved vaccines against foot-and-mouth disease epidemics
por: Park, Jong-Hyeon
Publicado: (2013)

Risk Factors for Neurologic Complications of Hand, Foot and Mouth Disease in the Republic of Korea, 2009
por: Kim, Seong Joon, et al.
Publicado: (2013)

Effect of Climatic Factors on Hand, Foot, and Mouth Disease in South Korea, 2010-2013
por: Kim, Bryan Inho, et al.
Publicado: (2016)

Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate
por: LEE, Hyang-Sim, et al.
Publicado: (2020)

Post-vaccination Monitoring to Assess Foot-and-Mouth Disease Immunity at Population Level in Korea
por: Park, Mi-Young, et al.
Publicado: (2021)

Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs
por: Jo, Hye-Eun, et al.
Publicado: (2019)

Synergistic effect of ribavirin and vaccine for protection during early infection stage of foot-and-mouth disease
por: Choi, Joo-Hyung, et al.
Publicado: (2018)

New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014–2015
por: Jo, Hye-Eun, et al.
Publicado: (2019)

The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine
por: Ko, Mi-Kyeong, et al.
Publicado: (2023)

Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses
por: Lee, Min Ja, et al.
Publicado: (2020)

The Potential Adjuvanticity of CAvant(®)SOE for Foot-and-Mouth Disease Vaccine
por: Ahn, Young-Hoon, et al.
Publicado: (2021)

Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine
por: Park, Min-Eun, et al.
Publicado: (2017)

Production of a Foot-and-Mouth Disease Vaccine Antigen Using Suspension-Adapted BHK-21 Cells in a Bioreactor
por: Park, Soonyong, et al.
Publicado: (2021)

Epidemiology and Burden of Diabetic Foot Ulcer and Peripheral Arterial Disease in Korea
por: Chun, Dong-il, et al.
Publicado: (2019)

Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs
por: Hwang, Ji-Hyeon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5kscba1jcgn4dajuq7lufhnn30